UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

CLINICAL AND IMMUNOGENETIC CHARACTERISTIC OF HEALTHY CHILDREN BORN TO MULTIPLE SCLEROSIS PATIENTS

Type of Article

In the Section

Index UDK:

Abstract

Purpose. To identify reliable predictor markers that indicate the possibility the development of a hereditary predisposition to MS based on the study of anamnestic, clinical, immunogenetic and neuroimaging features in practically healthy adult children born to parents with a sporadic form of this disease

Two groups of persons were examined: Primary group (practically healthy persons, born from sick parents) — 54 persons (27 men and 27 women) with an average age of 19.7 ± 2.0; observational group (persons born from healthy parents) — 20 persons (8 men and 12 women), with an average age of 20.5 ± 2.0). During the research the following points were studied: features of pregnancy and childbirth before the onset and against the background of MS in women who gave birth to healthy children; previous diseases (according to anamnesis), neurological status; peculiarities of immune status; prevalence of minor allele G (haplotype AG) in heterozygous individuals and prevalence major allele A (haplotype AA) in homozygous individuals; results of a neuroimaging study (MRI).

In the primary group, the majority of women before the onset of MS (68.5 ± 6.3 %) had healthy children through physiological childbirth (83.4 ± 5.1) %. Against the background of the disease neither relapses of MS nor other complications were detected in pregnant women. Diseases suffered by persons living with MS in their family anamnesis from the parents included frequent bacterial-viral infections (chicken pox, ARVI, chronic ENT pathology — and bronchopulmonary pathology), which were able to start and maintain autoimmune reactions as a result of hypersensibilization developed. According to immunological studies, some of the persons examined demonstrated signs of immune imbalance (deficiency of immunoregulatory cells CD4, CD8, liquid lymphocytosis, decrease in natural killer cells, and increase in lymphocytotoxic autoantibodies) which indicated the presence of an inflammatory process with an autoimmune component. Status studies revealed minimal neurological symptoms in a small number of individuals (those symptoms were not pathognomonic for MS and did not significantly affect quality of life. According to the MRI data, no “dormant” foci of demyelination were detected which indicates absence of a subclinical course of MS in the examined persons. According to data of genetic studies, a reliable predominance of the AA haplotype over the AG haplotype was revealed, which is associated with the development of MS.

Thus, the complex analysis of the received data gave an opportunity to distinguish “conditional” risk factors (high infectious index due to frequent bacterial-viral infections and, signs of immune imbalance) and anti-risk factors (absence of neurological symptoms, pathogenic for MS, absence of “dormant” foci of demyelination, according to MRI data, reliable prevalence of AA haplotype over the AG haplotype) which, taking into account the hereditary predisposition to MS, can contribute or hinder further possible development of the demyelinating process.

Pages

References

  1. Favorova O. O., Boyko A. N., Kulakova O. G. Rasseyannyy skleroz kak poligennoye zabolevaniye: sovremennoye sostoyaniye problemy. Genetika. 2010. T. 46, No. 3. S. 302—313. (In Russian).
  2. Boyko A. N., Gusev E. I. Dostizheniya v izuchenii problem rasseyannogo skleroza (obzor). Doktor. Ru. Nevrologiya, psikhiatriya. 2012. T. 73. No. 5. S. 9—15. (In Russian).
  3. Korobko D. S.,. Malkova N. A. i dr. Vliyanie geneticheskix faktorov na fenotipicheskuyu e’kspressiyu rasseyannogo skleroza. Zhurnal nevrologii i psixiatrii im. S. S. Korsakova. 2013. No. 2. S. 10-16.
  4. Ramagopalan S. Genetics and epidemiology of multiple sclerosis / S. Ramagopalan, A. Sadovnick // Primer on multiple sclerosis. 2011. P. 15—29.
  5. Familial multiple sclerosis: does consanguinity have a role? / M.  Al  Jumah, S.  Kojan, A.  A.  Khathaami [et  al.]  // Multiple Sclerosis. 2011. No.  17(4). Р.  487—489. DOI: https://doi.org/10.1177/1352458510390406.
  6. Balcerac A. Genetics and familial distribution of multiple sclerosis: A review / A. Balcerac, C. Louapre // Revue Neurologique. Vol. 178. Issue 6. June 2022. P. 512—520. DOI: https://doi.org/10.1016/j.neurol.2021.11.009.
  7. Voloshina N.P., Negreba T.V., Vasilovskiy V.V, Pertsev G.D., Pesotskaya K.O., Pogulyayeva T.N., Tereshchenko L.P., Chernenko M.E., Fedoseyev S.V. Sravnitelnaya klinicheskaya kharakteristika raznykh tipov techeniya semeynykh i sporadicheskikh form rasseyannogo skleroza. Ukrainskyi visnyk psykhonevrolohii. 2018. T. 26, vyp. 1 (94). S. 10—19. (In Russian).
  8. McElroy J. P. Multiple sclerosis genetics / J. P. McElroy, J. R. Oksenberg // Curr Top Microbiol Immunol. 2008. No. 318. Р. 45—72.
  9. Olsson Т. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Review / T. Olsson, L. F. Barcellos, L. Alfredsson // Nat. Rev. Neurol. 2017 Jan.13(1). Р. 25—36. DOI: https://doi.org/10.1038/nrneurol.2016.187.
  10. Vasylovskyi V. V. Prohrediientni typy perebihu rozsiianoho sklerozu: kliniko-patohenetychna kharakterystyka perebihu, prohnoz ta novi pidkhody do stratehii likuvannia: dys. … d-ra med. nauk. Kharkiv, 2019. 467 s. (In Ukrainian).
  11. Pogulyaeva T. M. Kliniko-imunohenetychna kharakterystyka khvorykh z sporadychnoiu ta simeinoiu formamy rozsiianoho sklerozu: dyferentsialna diahnostyka, prohnoz, vplyv vahitnosti ta polohiv pry dvokh formakh rozsiianoho sklerozu : dys. kandydata med. nauk. Kharkiv, 2020. 188 s.
  12. Nehreba T. V. Klinichna diahnostyka riznykh typiv perebihu rozsiianoho sklerozu. Zbirka anket: Svidotstvo pro avtorske pravo na naukovyi tvir No. 8675 vid 31.10.2003. (In Ukrainian).
  13. Voloshina N. P. , Vasilovskiy V. V., Chernenko M. E. Vliyaniye infektsionnogo faktora na sostoyaniye gematoentsefalicheskogo baryera u bolnykh rasseyannym sklerozom [The influence of the infectious factor on the state of the blood-brain barrier in patients with multiple sclerosis]. Ukrainskyi visnyk psykhonevrolohii [Ukrainian Bulletin of Psychoneurology]. 2013. Vol. 21, iss. 1 (74). P. 5—7. (In Russian).
  14. Koliada T. I., Voloshina N. P., Nehreba T. V. Porivnialna kharakterystyka imunnoho statusu pry riznykh typakh perebihu rozsiianoho sklerozu. Ukrainskyi visnyk psykhonevrolohii. 2004. T. 12, vyp. 2 (39). S. 88-94.
  15. Gandhi R. Role of the innate immune system in the pathogenesis of  multiple sclerosis / R.  Gandhi, A.  Laroni, H. L. Weiner // J Neuroimmunol. 2010 Apr 15. Vol. 221 (1—2). P. 7—14. DOI: https://doi.org/10.1016/j.jneuroim.2009.10.015.
  16. . Vasilovskij V. V., Voloshina N. P., Negreba T. V., Levchenko I. L. Sravnitel’naya strukturno-funkcional’naya xarakteristika immunnogo disbalansa u licz raznogo pola pri recidiviruyushhem i progredientny’x tipax techeniya rasseyannogo skleroza. Ukrainskyi visnyk psykhonevrolohii. 2014. T. 22, vyp. 1 (78). S. 28-36.
  17. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis / M. P. Wattjes, O. Ciccarelli, D. S. Reich [et al.]; Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group // Lancet Neurol. 2021. Aug. № 20(8). Р. 653—670. DOI: https://doi.org/10.1016/S1474-4422(21)00095-8.